Trade ClearPoint Neuro Inc - CLPT CFD

ClearPoint Neuro, Inc. Company profile

About Clearpoint Neuro Inc

ClearPoint Neuro, Inc. is a medical device company. The Company develops platforms for performing minimally invasive surgical procedures in the brain under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has three product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain; ClearTrace system, which is under development to be used to perform minimally invasive surgical procedures in the heart, and SmartFlow cannula, which is used in clinical trials to inject certain fluids directly into the brain. Its ClearPoint system is a neuro-navigation system designed for instruments or devices to treat a variety of neurological diseases and conditions and for performing biopsies. Its SmartFlow cannula is being used by pharmaceutical companies to deliver drugs and biologics under such company's clinical trials.

Financial summary

BRIEF: For the fiscal year ended 31 December 2021, Clearpoint Neuro Inc revenues increased 27% to $16.3M. Net loss increased from $6.8M to $14.4M. Revenues reflect Products: Biologics and drug delivery segment increase from $1.5M to $3.4M, Products: Functional neurosurgery segment increase of 23% to $7.7M. Higher net loss reflects Research and development costs increase of 92% to $9M (expense).

Equity composition

Common stock $0.01 Par, 5/12, 100M auth., 40,773,547 issd., less 325,830 shs. in Treas.@$1.8M. Insider own 1%.